Larry Worden Announces Retirement
Dallas, TX, April 7, 2017. MDxI CEO Kathi McGregor announces the retirement of Larry Worden, Founding Partner and President, from day-to-day operations of the company. Larry has been instrumental in the growth of the company over the past nine years and will remain a shareholder in the company. He will continue to leverage his 35+ years in the industry as a private consultant and speaker at industry meetings.
with any questions, or if you would like Larry’s contact information.
Mike Daniel Promoted to President
Dallas, TX, April 7, 2017. MDxI CEO Kathi McGregor announces the promotion of Mike Daniel, CTO, to President. Mike has 25+ years in the Information Technology industry and has been with MDxI for over 11 years. His background in systems integration, data analysis, and database administration has been instrumental in the development of our current data products. Mike will be spearheading our new Customer Relationship Management (CRM) consulting offering, as well as managing the company in partnership with Kathi.
MDxI Moves to New Offices
Dallas, TX, December 14, 2016. To accommodate our continued growth in providing IVD companies with the most definitive and complete information on the markets they serve, MDxI is relocating its offices effective January 30, 2017. We look forward to serving you from our new home at:
|Park Central 7•8•9|
|12750 Merit Drive|
|Dallas, TX 75251|
Our phone number, email and website will remain unchanged.
MDxI's Larry Worden Featured Speaker at the Association For Molecular Pathology's 5th Annual Analyst Day Forum
Dallas, TX, September 12, 2016. Larry Worden, Vice President and Senior Partner of Market Diagnostics International LLC (“MDxI”) will deliver an overview of the worldwide molecular diagnostics market to leading molecular diagnostics-focused analysts and private equity executives at the 5th annual Association for Molecular Pathology (“AMP”) Analyst Day, to be held in conjunction with this year’s annual meeting in Charlotte, NC. This is the fifth annual update that MDxI will provide to the attendees at this meeting.
Larry Worden to Moderate Expert Panel Discussion at the 7th World Boston CDx 2016
Dallas, TX, September 9, 2016. MDxI’s Vice President and Senior Partner, Larry Worden, will moderate an expert panel discussion on “Addressing the Challenges to Commercial Success for your CDx” at the 7th World CDx Boston Summit 2016 on Monday, October 18th.
MDxI To Present “Establishing The Value Of Diagnostic Tests” At The Next Generation Dx Summit
Dallas, TX, August 16, 2016. MDxI has organized a “Short Course” entitled “Establishing the Value of Diagnostic Tests” to be offered in conjunction with the eighth annual Next Generation Dx Summit being held on August 22-26, 2016 in Washington D.C.
DxMA Elects Lawrence Worden As President and Debra Harrsch As President-Elect
Dallas, TX, January 4, 2016. The Diagnostic Marketing Association (DxMA) is pleased to announce the election of Lawrence Worden of Market Diagnostics International, as president and Debra Harrsch of Brandwidth Solutions as president-elect to two-year terms running through the end of 2017.
Also elected to two-year leadership positions were Ned Gordon of Siemens Healthcare Diagnostics who will serve as treasurer and Narayan Krishnaswami of MilliporeSigma as secretary.
MDxI To Present At The ASM/AMP Analyst Symposium
Dallas, TX, December 22, 2015. Larry Worden, Vice President and Senior Partner of Market Diagnostics International LLC (“MDxI”) will deliver an overview of the key trends in the infectious disease testing market to leading infectious disease diagnostics-focused analysts at the Analyst Symposium sponsored by the American Society for Microbiology (ASM) and Association for Molecular Pathology (“AMP”) Analyst Symposium, to be held in conjunction with the 34th Annual J.P. Morgan Healthcare Conference on January 13, 2016.